8-K

Company

Black Diamond Therapeutics, Inc.

Filed

November 6, 2025

Period of Report

November 6, 2025

Accession Number

0001701541-25-000038

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →